BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2013
View Archived Issues
Companies enter collaboration to develop Tregitope immune-modulating technology
Read More
Boston Scientific set to launch Promus Premier stent system in Europe
Read More
Japanese authorities remove condition for approval from Abraxane
Read More
Priority review granted to Bayer's NDA for radium-223
Read More
Amylin Pharmaceuticals patents new fusion proteins
Read More
GlaxoSmithKline presents novel TRPV4 antagonists
Read More
GlaxoSmithKline discloses novel tyrosine-protein kinase inhibitors
Read More
AstraZeneca synthesizes new inhibitors of mutated forms of EGFR
Read More
Pfizer designs new glucagon receptor antagonists
Read More
Xenetic Biosciences signs research agreement
Read More
ALX-0061 demonstrates good efficacy and safety in RA patients
Read More
Agilent Technologies and Sera Prognostics form partnership
Read More
Dako and Pfizer to collaborate on companion diagnostics
Read More
Peregrine Pharmaceuticals reports results from phase II bavituximab trial
Read More
Xencor begins phase Ib/IIa trial of XmAb-5871
Read More
GGF2 enhances post-stroke recovery of sensorimotor functions in vivo
Read More
Prolor Biotech's hGH-CTP receives orphan drug designation in Europe
Read More
Phase III Fibrocaps trial achieves safety milestone
Read More
Phase III study finds no benefit for DP-b99 in acute ischemic stroke
Read More
Lundbeck reflects on highlights of 2012
Read More
Novo Nordisk gains price approval in Japan for once-daily basal insulin
Read More
EMA grants orphan designation to BHR Pharma's investigational agent for traumatic brain injury
Read More
Photoimmunotherapy enhances accumulation of nanosized chemotherapy in tumors
Read More
Lentigen obtains FDA orphan designation for novel gene therapy for glioblastoma multiforme
Read More
